Mednow Investor Presentation Deck

mednow General Synergies Infrastructure Synergies Accretive Acquisitions Create Significant Synergies in the Mednow Ecosystem Description Key Metrics - revenue, profits, patients 1 Cross-Selling - more robust offering to win clients and patients National Expansion Technology - integrate into streamlined technology offering Advanced Capabilities -at-home care / specialty pharmacy services People - adds key primary care and specialist physician roster, patient base and industry relationships ITSX-V: MNOW I OTC-QX: MDNWF Medvisit . At-home doctor services ● $3M revenue, -30% gross margin > > > ● InfusiCare Pharmacy that specializes in biologics for rheumatology and gastroenterology ● $9.3M revenue, -10% gross margin ● Liver Specialty Group Pharmacy that specializes in hepatology and the treatment of liver disease . $21.3M revenue, ~10% gross margin 1.2021 fiscal year end ✓ 17 ØST

View entire presentation